Dipyridamole NDC 0115-1072

NDC codes

FDA NDC Directory

Product NDC (as listed)0115-1072Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00115-1072Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0115-1072-01	00115107201	100 TABLET in 1 BOTTLE (0115-1072-01)Marketed from Aug 30, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dipyridamole
Generic name (nonproprietary): dipyridamole
Active ingredients: Dipyridamole — 75 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals of New York LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040782
Marketing start: Aug 30, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Platelet Aggregation (Physiologic effect)
Identifiers: Product ID 0115-1072_02250a0f-40e1-4f73-8ead-1be26f78edc8SPL ID 02250a0f-40e1-4f73-8ead-1be26f78edc8SPL set ID a18b2af5-7c4a-4b7f-92c7-8a76e34da373RxCUI 197622, 309952, 309955UNII 64ALC7F90CUPC 0301151072015, 0301151071018, 0301151070011
Pharmacologic class: Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400115107201 followed by a unit qualifier and the quantity

Package 00115-1072-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040782

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040782
Product	Strength	Form · route	Labeler	Product NDC
Dipyridamole	Dipyridamole 25 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	0115-1070
Dipyridamole	Dipyridamole 50 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	0115-1071